Yüklüyor......
Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands
One major barrier in the development of pancreas cancer therapeutics is the selective delivery of the drugs to their cellular targets. We have developed previously several sigma-2 ligands and reported the discovery of a component of the receptor for these ligands. Several sigma-2 ligands have been s...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3982787/ https://ncbi.nlm.nih.gov/pubmed/22763259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2012.05.014 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|